The following is a summary comments attributed to Commissioner of Food and Drugs – Food and Drug Administration, Stephen M. Hahn, M.D. Every step we have taken as part of our approach to COVID-19 testing has been a careful balancing of risks and benefits in order to meet the urgent public health needs as we combat this new pathogen. We have moved quickly and thoughtfully, and we are continuing to learn and adapt based on the real-world experience and data we’re seeing. Frontline h...